KHC vs LYRA · P/E 12, rev $12.31B vs rev $1.5M
Kraft Heinz Co (KHC) versus Lyra Therapeutics Inc (LYRA) — a side-by-side from cached financials, not a winner call.
Kraft Heinz Co (KHC) is a packaged foods company listed on US.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Latest reported KHC revenue for 2026-06-27 was $12.31B. Net income was -$4.66B. KHC currently screens at market cap $31.55B and trailing P/E 12.2.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
KHC currently screens at market cap $31.55B and trailing P/E 12.2. LYRA currently screens at market cap $14.4M.
Not investment advice. Open the KHC and LYRA stock pages for the full models.
Not investment advice.